ZLNA Zelluna ASA

1.518USD14.70 NOK · OSL-4.85%Mkt Cap: 45.32M USDP/E: —

Zelluna ASA, a clinical-stage biotechnology company, engages in the development of T-cell receptor guided natural killer cell therapies in Norway. It develops ZI-MA4-1 which is in Phase I clinical trial for the treatment…